|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
09688 ZAI LAB
Nominal 
14.320 -0.740 (-4.914%) | 2025/12 - Final USD(K$) | %Chg (Compare to Final) | 2024/12 USD(K$) | 2023/12 USD(K$) | 2022/12 USD(K$) | 2021/12 USD(K$) | |
| Turnover | 460,156 | 15.331% | 398,988 | 266,719 | 215,040 | 144,312 |
| Cost of Sales | -- | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- | -- |
| 2025/12 - Final USD(K$) | %Chg (Compare to Final) | 2024/12 USD(K$) | 2023/12 USD(K$) | 2022/12 USD(K$) | 2021/12 USD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | 3,540 | -33.208% | 5,300 | 7,006 | 3,113 | (10,201) | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | -- | -- | |
| Profit / (Loss) before Taxation | (178,464) | -30.587% | (257,103) | (334,620) | (443,065) | (703,414) | |
| Taxation | 2,927 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | (221) | (1,057) | |
| Profit / (Loss) Attributable to Shareholders | (175,537) | -31.725% | (257,103) | (334,620) | (443,286) | (704,471) | |
| 2025/12 - Final USD(K$) | %Chg (Compare to Final) | 2024/12 USD(K$) | 2023/12 USD(K$) | 2022/12 USD(K$) | 2021/12 USD(K$) | |
| Net Finance Costs / (Income) | (47,430) | 140.590% | (19,714) | (24,947) | 41,821 | (6,851) |
| Depreciation & Amortisation | 15,010 | 19.544% | 12,556 | 9,029 | 8,227 | 6,487 |
| Directors' Emoluments | -- | -- | 18,068 | 16,856 | 14,610 | 13,337 |
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/12 - Final | %Chg (Compare to Final) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | -16.000 | -38.462% | -26.000 | -35.000 | -46.000 | -76.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | (0.217) | (0.205) | (0.384) | (0.591) |
| NBV per share ($) | 0.639 | -- | 0.768 | 0.805 | 1.068 | 1.444 |
| Remarks: | Real time quote last updated: 02/03/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K$) | USD -175,537 |
| %Change | -31.725% |
| EPS / (LPS) | USD -0.160 |
| NBV Per Share ($) | USD 0.639 |